<DOC>
	<DOCNO>NCT00591071</DOCNO>
	<brief_summary>During hospitalization intensive care unit ( ICU ) , occurrence blood glucose imbalance frequent associate increased mortality . These observation result hypothesis intensive insulin therapy design control blood glucose would improve prognosis patient admit ICU . In prospective , randomize , single center study surgical ICU majority patient undergone cardiac surgery , intensive insulin therapy objective maintain glycemia 110 mg/dl ( 6.1 mmol/L ) provide significant reduction ICU mortality hospital mortality compare group glycemic objective 200 mg/dl . In recent publish article , beneficial effect intensive insulin therapy seem less obvious randomize single center study medical ICU . One potential factor limit impact therapeutic strategy like one absence achieve strict glycemic control patient intensive insulin therapy . Additionally , implementation therapeutic strategy result increase risk hypoglycemia , consequence morbidity remain unclear . The aim study determine , mixed population medical surgical patient admit ICU , require artificial ventilation expect duration 48 hour , impact effective strict glycemic control ( &lt; 6,1 mmol/l ) compare conventional glycemic control ( &lt; 11mmol/l ) hospital mortality .</brief_summary>
	<brief_title>Impact 2 Blood Glucose Levels Hospital Mortality Patients Admitted ICU</brief_title>
	<detailed_description>In randomization arm , continuous insulin infusion use via venous route administration . Rapid action insulin Novorapid HM ( Novo Nordisk , Copenhagen , Denmark ) use . ICU patient management require many intravenously administer treatment limited number venous line ( catecholamine , sedation , feeding , vascular filling , antioticsâ€¦ ) . This situation enable dedicate infusion line intravenous administration insulin . Despite continuous administration insulin infusion , concomitant administration treatment infusion line obviously lead significant variation flow insulin actually deliver , lead variation blood glucose adjustment secondary inappropriate dose insulin . To limit phenomenon , OCTOPUS ( Vygon , Ecouen , France ) type infusion connector add . The infusion connector make 2 infusion line one exclusively dedicated insulin therapy subsequently limit risk variation insulin administration flow . The determination number subject include carry use 45 % hospital mortality hypothesis conventional glycemic control group . 32 % hospital mortality hypothesis strict glycemic control group .</detailed_description>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Benzocaine</mesh_term>
	<criteria>18 year age require mechanical ventilation expect duration 48 hour admission cardiac arrest admission attempt drug autolysis acute drunkenness admission hyperosmolar and/or ketoacidosis coma admission massive cerebral hemorrhage admission another ICU admission surgery without organ failure respiratory support ( FiO2 50 % PeeP 5cm H2O ) inclusion another interventional study patient next kind refusal study participation pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>hyperglycemia</keyword>
	<keyword>insulin treatment</keyword>
	<keyword>intensive care</keyword>
	<keyword>hypoglycemia</keyword>
	<keyword>mechanical ventilation</keyword>
	<keyword>critically ill patient</keyword>
</DOC>